France Bariatric Surgery Devices Market Analysis

France Bariatric Surgery Devices Market Executive Summary

The France Bariatric Surgery Devices Market is at around $73.2 Mn in 2023 and is projected to reach $97.6 Mn in 2030, exhibiting a CAGR of 4.2% during the forecast period 2023-2030.

Bariatric surgery, also called weight loss surgery, is a category of surgical operations intended to help people with obesity lose weight. Healthcare providers may recommend bariatric surgery if other weight loss methods have failed and if obesity appears to pose a greater risk to your health than surgery. Bariatric surgery procedures work by modifying your digestive system usually your stomach, and sometimes also your small intestine to regulate how many calories you can consume and absorb. They can also reduce the hunger signals that travel from your digestive system to your brain. These procedures can help treat and prevent many metabolic diseases related to obesity, including diabetes and fatty liver disease. Bariatric surgery is the most successful long-term treatment for class III obesity. According to the National Institutes of Health (NIH), it is nearly impossible for people with class III obesity to sustain weight loss through diet and exercise alone. Once your body has registered your higher weight as “normal,” it continues to try to return to that weight. Bariatric surgery works by changing how your body manages what you eat, allowing healthy diet and lifestyle changes to be effective for sustained weight loss and health.

Over the last 25 years, obesity has grown in France, especially among youth. In 2020, one in two adults was dealing with overweight or obesity in the country. Indeed, 47 percent of French adults were overweight, of which 17 percent suffered from obesity. Compared to 1997, obesity rates in France have notably quadrupled among 18–24-year-olds. Therefore, the market is driven by various factors such as increasing demand for minimally invasive surgeries, rising incidence of obesity, technological advancements, rising awareness about bariatric surgery.

The prominent players in the market are Apollo Endosurgery, TransEnterix, Stryker, Medtronic, B. Braun, Peters Surgical, Johnson & Johnson, Cousin Surgery among others.

Market Dynamics

Market Drivers

Rising obesity rates in France: France has been experiencing a steady increase in obesity rates over the past few decades. According to Statistics France, 47 percent of French adults were overweight, of which 17 percent suffered from obesity. This trend is likely to continue, creating a larger potential patient pool for bariatric surgeries and driving demand for related devices.

Rising awareness and trust in bariatric surgery procedures among the general population: Public awareness campaigns and educational initiatives are increasing the understanding of bariatric surgery procedures. As more people become aware of the benefits and safety of these procedures, demand is growing.

Rising comorbidities: Increasing comorbidities associated with obesity, such as hypertension, type 2 diabetes, cardiovascular disease, and cancer, driving demand for effective obesity treatments. The increasing prevalence of obesity-related comorbidities is driving the need for effective treatments. Bariatric surgeries are seen as a key solution to manage these comorbidities.

Market Restraints

Regulatory Challenges: Uncertain regulatory environment for medical devices in emerging markets, leading to delays in approvals. Regulatory bodies in emerging markets often have unclear or changing guidelines, leading to delays in the approval process for new medical devices. This uncertainty hinders market growth in these regions.

Postoperative challenges associated with bariatric surgeries, such as complications and malnutrition: Bariatric surgeries are associated with complications, such as leaks, bleeding, and infections. Patients may also experience malnutrition or vitamin deficiencies after surgery, which can impact their health. These challenges deter patients from undergoing bariatric surgeries.

Limited availability of skilled bariatric surgeons: There's a shortage of surgeons specially trained in bariatric procedures in France, leading to long wait times in some regions. This shortage limits market growth and patient access to these treatments.

Regulatory Landscape and Reimbursement Scenario

Bariatric surgery devices are regulated within a comprehensive framework that combines EU-wide and national regulations. Devices must obtain CE marking and undergo assessment by the French National Agency for Medicines and Health Products Safety (ANSM). The High Authority of Health (HAS) evaluates their clinical and economic value for potential reimbursement.

France's universal healthcare system generally covers bariatric surgery and related devices, subject to specific criteria such as BMI thresholds and failed previous weight loss attempts. Reimbursement rates for specific devices are government-set and may vary. The system requires ongoing post-market surveillance, and manufacturers must report adverse events to ANSM. While the national health insurance provides primary coverage, complementary private insurance may offer additional benefits.

Competitive Landscape

Key Players

Here are some of the major key players in the France Bariatric Surgery Devices Market:

• Apollo Endosurgery Inc.
• Johnson & Johnson (Ethicon Inc.)
• Conmed Corporation
• Medtronic PLC (Covidien)
• TransEnterix Inc.
• B. Braun SE
• Olympus Corporation
• Stryker
• Peters Surgical
• Sterifil